Replies to post #276894 on Anavex Life Sciences Corp (AVXL)

[Investor2014]

The P2b/3 AD trial will readout sometime in 2022, not next year.

[Investor2014]

Next year we might get readout in the paediatric Rett trial. If that and the two adult Rett trials are positive Anavex will have laid a nice foundation as a neurodevelopmental and neurodegenerative platform company.

[baltimorebullet]

Wondering why they didn't choose Alzheimer's for Anavex3-71's maiden voyage.

[LakeshoreLeo1953]

Being much more the Market investor and not the bio scientist,
I am somewhat amused when the discussion of dosage comes up.

It is my understanding that efficacy is and will be tied to serum
concentrations and to that end different dosages may continue
to be applied appropriately.

Not at all sure the manufacturing efficiencies would be 1:1
corelated to dosage size. That said....to exaggerate...one tiny pill
beats a handful of horse capsules.